The federal budget deficit was $1.7 trillion in the first six months of fiscal year 2021, CBO estimates—almost $1 trillion more than the deficit recorded during the same period last year.
CBO assesses trends in spending for prescription drug research and development (R&D) and the introduction of new prescription drugs. CBO also examines factors that determine how much drug companies spend on R&D.
